Liraglutide
A Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 Diabetes
Novo Nordisk · Phase 2 · Completed · Enrollment 834
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.